Rutherford Health - Appointment of Non-Executive Director London Stock Exchange
RNS Number : 1992N
Rutherford Health PLC
23 September 2019

23 September 2019


Rutherford Health Plc

Director Appointment


Rutherford Health Plc ("Rutherford" or the "Company") are pleased to announce that the Company has appointed Tim Irish to the Board as a Non-Executive Director with immediate effect.

Tim has worked in the life sciences industry for over thirty years. His career has spanned global health technology companies across Europe and North America, including GSK, GE and Philips, the latter two in senior positions responsible for medical imaging. Tim also currently holds a number of non-executive positions in health and technology related entities. Tim is currently the Vice Chair of the National Institute for Health and Care Excellence (NICE), having joined the board of NICE in April 2015. Tim Irish is currently Professor of Practice at Kings College London.

Mike Moran, chief executive officer of Rutherford Health plc, said: "We are delighted to welcome Tim to the board. His outstanding international experience will be a great asset to the company. His extensive knowledge of the opportunities and challenges across the healthcare sector will be invaluable as we continue to develop the range of services we offer cancer patients."

Tim Irish said, "I am delighted to be joining the board of such a dynamic, fast growing company and to use my experience in the healthcare industry to support its business growth.  Proton Beam Therapy is now an established treatment method and I look forward to helping to make the technology more widely adopted in the UK".   

Timothy Norris Irish, aged 55, is or has been a director of the following companies or a partner in the following partnerships during the last five years:



eZono AG

Feedback PLC

Fiagon AG Medical Technologies

ImaginAb, Inc.

National Institute for Health and Care Excellence

Pembrokeshire Retreats Limited

Quirem Medical B.V.

SCI Irish


Anthem Schools Trust (formerly CfBT Schools Trust)

Bioxydyn Limited

Computabound Limited

Deltex Medical Group PLC

Life Sciences Hub Wales Limited

Nexstim Oyj

Styrene Systems Ltd

The Centre For School Standards Limited

TTS Pharma Limited

Version Solutions Limited (formerly Patech Solutions Limited)



There is no further information that is required to be disclosed pursuant to paragraph 21 of Appendix 1 to the NEX Exchange Growth Market - Rules for Issuers.

The information contained within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014. Upon the publication of this announcement, this inside information is now considered to be in the public domain.


The directors of Rutherford Health plc accept responsibility for this announcement.





Rutherford Health Plc


Michael Moran, Chief Executive Officer

Tel: +44 (0) 16 3381 0661

Grant Thornton (Corporate Adviser)

Tel: +44 (0) 20 7383 5100

Colin Aaronson/ Jamie Barklem/ Niall McDonald


Media House International


Ramsay Smith

07788 414 856 or



This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact or visit